The use of molecular markers as a method to predict the response to neoadjuvant therapy for advanced stage rectal adenocarcinoma.

The use of molecular markers as a method to predict the response to neoadjuvant therapy for advanced stage rectal adenocarcinoma.

Item
http://www.wikidata.org/entity/Q46037079
Predictive value of APAF-1 and COX-2 expression in pathologic complete response to neoadjuvant chemoradiotherapy for patients with locally advanced rectal adenocarcinoma.Association between the cytogenetic profile of tumor cells and response to preoperative radiochemotherapy in locally advanced rectal cancer.KRAS Mutation Status Is Not a Predictor for Tumor Response and Survival in Rectal Cancer Patients Who Received Preoperative Radiotherapy With 5-Fluoropyrimidine Followed by Curative Surgery.Role of BAX for outcome prediction in gastrointestinal malignancies.Distance to the anal verge is associated with pathologic complete response to neoadjuvant therapy in locally advanced rectal cancer.Anti-cancer applications of titanocene-functionalised nanostructured systems: an insight into cell death mechanisms.Clinical Significance of the Endoscopic Finding in Predicting Complete Tumor Response to Preoperative Chemoradiation Therapy in Rectal Cancer.Role of KRAS mutation as predictor of pathologic response after neoadjuvant chemoradiation therapy for rectal cancer.Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes.Oncogene mutation profile predicts tumor regression and survival in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and radical surgery.Predictive markers of chemoradiotherapy for rectal cancer: comparison of biopsy specimens taken before and about 1 week after the start of chemoradiotherapy.Histogram analysis of ADC in rectal cancer: associations with different histopathological findings including expression of EGFR, Hif1-alpha, VEGF, p53, PD1, and KI 67. A preliminary study.The role of epithelial mesenchymal transition and resistance to neoadjuvant therapy in locally advanced rectal cancer
P2860

The use of molecular markers as a method to predict the response to neoadjuvant therapy for advanced stage rectal adenocarcinoma.

Item
http://www.wikidata.org/entity/Q46037079
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
The use of molecular markers a ...... d stage rectal adenocarcinoma.
@en
The use of molecular markers a ...... d stage rectal adenocarcinoma.
@nl
type
label
The use of molecular markers a ...... d stage rectal adenocarcinoma.
@en
The use of molecular markers a ...... d stage rectal adenocarcinoma.
@nl
prefLabel
The use of molecular markers a ...... d stage rectal adenocarcinoma.
@en
The use of molecular markers a ...... d stage rectal adenocarcinoma.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
The use of molecular markers a ...... d stage rectal adenocarcinoma.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1463-1318.2011.02697.X
P433
P478
P577
P698
P921